Literature DB >> 4041955

Blood glucose control by an artificial endocrine pancreas in a patient with phaeochromocytoma.

M Hamaji, M Miyata, R Kawamori, M Shichiri, T Mashimo, K Nakao, Y Kawashima.   

Abstract

In a patient with phaeochromocytoma who presented with unstable diabetes mellitus, an artificial endocrine pancreas was used intraoperatively. Anaesthetic agents included enflurane, nitrous oxide and oxygen. Nicardipine was used to control hypertensive episodes. The initial blood glucose concentration was 173 mg X dl-1 and it decreased to 110 mg X dl-1 in response to insulin infusion, but plasma catecholamines were markedly increased. Seventy minutes later, the glucose concentration increased progressively to 249 mg X dl-1 despite massive insulin infusion, maximally 5.64 mU X kg-1 X min-1. The blood glucose concentration reached a peak at the time of the ligation of the venous drainage from the tumour and the peak was coincident with that of plasma catecholamine levels (epinephrine: 20.8 ng X ml-1, norepinephrine 16.4 ng X ml-1). Both glucose and catecholamine concentrations decreased promptly after removal of the tumour and hypotension followed likely because of a persistent vasodilatatory effect of nicardipine. The profiles of blood glucose, insulin and glucose infusion rates provided by the artificial endocrine pancreas suggested that the insulin resistance began to be reversed shortly after removal of the phaeochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041955     DOI: 10.1007/bf03010805

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  9 in total

1.  Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell.

Authors:  R Kawamori; M Shichiri; Y Goriya; Y Yamasaki; Y Shigeta; H Abe
Journal:  Acta Endocrinol (Copenh)       Date:  1978-02

2.  Fluorimetric determination of catecholamines using glycylglycine as the reagent for post-column derivatization.

Authors:  T Seki; Y Yamaguchi
Journal:  J Chromatogr       Date:  1984-04-06

3.  Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species.

Authors:  S Higuchi; Y Shiobara
Journal:  Xenobiotica       Date:  1980-06       Impact factor: 1.908

4.  Phaeochromocytoma and postoperative hypoglycaemia.

Authors:  R Martin; B St-Pierre; O R Moliner
Journal:  Can Anaesth Soc J       Date:  1979-07

5.  Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.

Authors:  E L Bravo; R C Tarazi; R W Gifford; B H Stewart
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

6.  Estimation of catecholamines in human plasma by ion-exchange chromatography coupled with fluorimetry.

Authors:  M Hamaji; T Seki
Journal:  J Chromatogr       Date:  1979-08-21

7.  Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade.

Authors:  D Serfas; D M Shoback; B H Lorell
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

8.  Hypoglycemia following excision of pheochromocytoma.

Authors:  G E Wilkins; N Schmidt; W A Doll
Journal:  Can Med Assoc J       Date:  1977-02-19       Impact factor: 8.262

9.  Hypoglycemia as a complication of removal of a pheochromocytoma.

Authors:  C T Allen; D Imrie
Journal:  Can Med Assoc J       Date:  1977-02-19       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.